From: Transforming research to improve therapies for trauma in the twenty-first century
Target | Compound/intervention | References |
---|---|---|
Oxygen carriers | Human hemoglobin | |
Perfluorocarbons | [89] | |
Platelet dysfunction | Anti-HMGB-1 | [90] |
Synthetic platelet (particles) | ||
Cold or frozen platelets | [93] | |
Platelet vesicles | [94] | |
Endothelial permeability | rhADAMTS13 | [95] |
Plasma | [95] | |
Albumin | [96] | |
Tyrosine kinase inhibitors | [97] | |
Vasculotide | [98] | |
Heparan sulfate | [99] | |
Antithrombin | [100] | |
Adiponectin | [101] | |
(Vesicles from) stem cells | [102] | |
Overshoot damage molecules | Hexadimethrine bromide | [103] |
DNAse-1 | [104] | |
Overshoot inflammation | JAK inhibitor Baricitinib | [105] |
Macrophage migration inhibitor ISO-1 | [106] | |
Lipid mediator Resolvin D1 | [107] | |
NADPH oxidase inhibitor diphenylene iodonium | [108] | |
Complement activation inhibitor nomacopan | [109] | |
Hormones | Estrogen | [110] |
Blood purification techniques | Hemoadsorption | [111] |